SANKAR NAVANEETHAN to Lipids
This is a "connection" page, showing publications SANKAR NAVANEETHAN has written about Lipids.
Connection Strength
0.272
-
Association between intensity of statin therapy and mortality in persons with chronic kidney disease. Nephrol Dial Transplant. 2020 02 01; 35(2):312-319.
Score: 0.131
-
Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol. 2013 Jun; 8(6):945-52.
Score: 0.081
-
A Whole-Grain Diet Reduces Cardiovascular Risk Factors in Overweight and Obese Adults: A Randomized Controlled Trial. J Nutr. 2016 Nov; 146(11):2244-2251.
Score: 0.026
-
Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2012 Aug 21; 157(4):263-75.
Score: 0.020
-
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ. 2008 Mar 22; 336(7645):645-51.
Score: 0.014